Iovance Biotherapeutics, Inc. (IOVA) dividend history
IOVANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3087% above fair value
$7.48−0.05 (-0.66%)
Close on Nov 18, 2026Market cap $3.39BP/E –Yield –
Dividends
Iovance Biotherapeutics has not reported a dividend
No dividend per share appears in Iovance Biotherapeutics's annual filings since fiscal 2010.
See a number that looks wrong?